allogeneic mesenchymal bone marrow cells

Allogeneic mesenchymal bone marrow cells are multipotent stromal cells derived from the bone marrow of a donor and administered to a recipient. These cells can differentiate into various cell types including osteoblasts, chondrocytes, myocytes, and adipocytes. They possess immunomodulatory properties—such as low expression of MHC class I and undetectable MHC class II—which allow them to evade immune rejection and be used safely in an allogenic setting[1][5]. Their primary mechanisms include modulation of inflammatory responses and secretion of trophic factors that promote tissue repair and regeneration[2][5]. Allogeneic BM-MSCs have been investigated for a range of indications including musculoskeletal disorders (e.g., lumbar facet joint arthropathy), osteogenesis imperfecta, idiopathic pulmonary fibrosis (IPF), Parkinson’s disease, graft-versus-host disease prevention during transplantation, degenerative disc disease/low back pain[4][6][7][8][9]. Clinical studies indicate high safety profiles with minimal adverse events; they are typically manufactured under stringent quality controls to ensure purity and potency[7].

Other names

allogeneic bone marrow-derived mesenchymal stem cellsallogeneic BM-MSCsallogeneic MSCs from bone marrowallogeneic human mesenchymal stem cells (bone marrow source)